Daniel Suzuki
Psychiatry · San Marino, CANPI 1811025679
Payments from drug & device makers
Across 1,259 payments — averaging $684.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$282K
- Otsuka America Pharmaceutical, Inc.$187K
- E.r. Squibb & Sons, L.L.C.$186K
- Alkermes, Inc.$118K
- Axsome Therapeutics, Inc.$57K
- Takeda Pharmaceuticals U.S.A., Inc.$23K
- plus $10K from 21 others
What the payments were for
- Consulting fees$77,7039%
- Speaking & faculty fees$692,77280%
- Travel & lodging$54,9586%
- Food & beverage$36,5994%
- Education$2030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 366 | $281,661 |
| Otsuka America Pharmaceutical, Inc. | 235 | $187,206 |
| E.r. Squibb & Sons, L.L.C. | 186 | $185,518 |
| Alkermes, Inc. | 153 | $118,063 |
| Axsome Therapeutics, Inc. | 64 | $56,739 |
| Takeda Pharmaceuticals U.S.A., Inc. | 55 | $23,076 |
| Eisai Inc. | 6 | $2,820 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $2,145 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 17 | $1,268 |
| AbbVie(2 entities) | 45 | $873 |
| Janssen Scientific Affairs, LLC | 6 | $500 |
| Sunovion Pharmaceuticals Inc. | 19 | $479 |
| Lundbeck LLC | 26 | $479 |
| Teva Pharmaceuticals USA, Inc. | 12 | $348 |
| Neurocrine Biosciences, Inc. | 8 | $197 |
| Vanda Pharmaceuticals Inc. | 6 | $186 |
| Tris Pharma Inc | 7 | $117 |
| Bausch Health US, LLC | 6 | $109 |
| Ironshore Pharmaceuticals Inc. | 5 | $99 |
| Almatica Pharma LLC | 5 | $91 |
| Corium, LLC | 3 | $76 |
| Neos Therapeutics, LP | 2 | $43 |
| Neuronetics, Inc. | 1 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Merck | 2 | $32 |
| Indivior Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$276,656
- LYBALVI$268,077
- ARISTADA$205,286
- REXULTI$184,586
- COBENFY$127,614
- Auvelity$55,698
- ARISTADA INITIO$41,679
- TRINTELLIX$22,115
- Dayvigo$2,820
- CAPLYTA$1,686
- ABILIFY MAINTENA$879
- INVEGA SUSTENNA$399
- INVEGA TRINZA$249
- ABILIFY ASIMTUFII$127
- INVEGA$125
- VRAYLAR$122
- UZEDY$115
- LATUDA$105
How this compares
$862,235 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 78 | $55,760 |
| Lurasidone Hcl | 33 | $12,690 |
| LexaproEscitalopram Oxalate | 12 | $5,213 |
| Duloxetine Hcl | 198 | $4,956 |
| Aripiprazole | 89 | $3,745 |
| Bupropion XlBupropion Hcl | 88 | $2,646 |
| Quetiapine Fumarate | 67 | $1,986 |
| Lamotrigine | 88 | $1,466 |
| Vilazodone Hcl | 16 | $1,386 |
| Escitalopram Oxalate | 75 | $1,141 |
| Trazodone Hcl | 106 | $1,022 |
| Fluoxetine Hcl | 24 | $1,003 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $844 |
| Divalproex Sodium ErDivalproex Sodium | 16 | $843 |
| Mirtazapine | 25 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $23,076 | $55,76078 claims |
| AbbVieLexapro | $873 | $5,21312 claims |
| Almatica Pharma LLCSertraline Hcl | $91 | $36865 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Marino
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.